Variant report
Variant | rs2325752 |
---|---|
Chromosome Location | chr17:45921906-45921907 |
allele | A/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:45918600-45922600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr17:45918800-45922400 | Enhancers | Fetal Intestine Large | intestine |
3 | chr17:45918800-45924600 | Weak transcription | Spleen | Spleen |
4 | chr17:45919000-45922000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
5 | chr17:45919000-45922200 | Enhancers | Fetal Intestine Small | intestine |
6 | chr17:45919200-45928000 | Weak transcription | Right Atrium | heart |
7 | chr17:45919400-45922000 | Enhancers | Stomach Mucosa | stomach |
8 | chr17:45919800-45922000 | Enhancers | Duodenum Mucosa | Duodenum |
9 | chr17:45920200-45922600 | Enhancers | Hela-S3 | cervix |
10 | chr17:45920200-45922600 | Enhancers | HMEC | breast |
11 | chr17:45920200-45923200 | Enhancers | Fetal Lung | lung |
12 | chr17:45920200-45923800 | Enhancers | K562 | blood |
13 | chr17:45920400-45922800 | Enhancers | Placenta Amnion | Placenta Amnion |
14 | chr17:45920600-45922600 | Enhancers | Osteobl | bone |
15 | chr17:45920800-45923400 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
16 | chr17:45920800-45923800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
17 | chr17:45921000-45924600 | Weak transcription | Pancreas | Pancrea |
18 | chr17:45921000-45927200 | Weak transcription | A549 | lung |
19 | chr17:45921200-45922400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr17:45921200-45922400 | Enhancers | HepG2 | liver |
21 | chr17:45921200-45923800 | Weak transcription | NHEK | skin |
22 | chr17:45921200-45926000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
23 | chr17:45921600-45922000 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |
24 | chr17:45921600-45922000 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
25 | chr17:45921600-45922200 | Bivalent Enhancer | Placenta | Placenta |
26 | chr17:45921600-45922800 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
27 | chr17:45921800-45922000 | Flanking Active TSS | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
28 | chr17:45921800-45922000 | Bivalent Enhancer | H9 Cell Line | embryonic stem cell |
29 | chr17:45921800-45922000 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin02 | Skin |
30 | chr17:45921800-45922000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
31 | chr17:45921800-45922800 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
32 | chr17:45921800-45922800 | Enhancers | Lung | lung |
33 | chr17:45921800-45923600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
34 | chr17:45921800-45923800 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
35 | chr17:45921800-45924200 | Genic enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |